FTC
-
FTC Challenges Pharmaceutical Patents – Wants Fair Competition in Medical Industry
The U.S. Federal Trade Commission (FTC) challenges 110 medical patents, including those for asthma inhalers, listed with the FDA, disputing their accuracy and relevance. Major pharmaceutical companies such as AbbVie, AstraZeneca, and Teva are under…
-
Microsoft’s $69 Billion Video Game Takeover Faces Regulatory Battle in Court
Federal regulators clash with Microsoft in a court battle over the proposed $69 billion takeover of Activision Blizzard. The deal’s impact on video gaming and competition is under scrutiny, while Microsoft emphasizes broader accessibility and…
-
The Impact of Microsoft’s Acquisition of Activision Blizzard: Competition Concerns and Market Dynamics
Analyzing the potential consequences of Microsoft’s acquisition of Activision Blizzard on competition and market dynamics in gaming. Learn more.